Healthcare Marketing Blogs

03|20|25

SXSW 2025: A Mandate, A Path, A Tool

At SXSW 2025, we heard loud and clear: Pharma marketers are facing the biggest challenge of our careers. But it's also the most rewarding challenge, and one that has sharpened our superpowers .In this POV, we discuss how we can harness these opportunities to navigate the challenges ahead.

03|18|25

The Digital Determinants of Health: Shaping the Future of Well-Being

Download the POV, The Digital Determinants of Health, to discover how understanding digital determinants of health can transform pharmaceutical strategies and drive business success.

03|13|25

AI With A Human Touch: Ensuring Authenticity in AI Marketing

In this POV, Morgan Hartzell, VP, Client Services, explores several key strategies to ensure marketing remains genuine and trustworthy, while still leveraging the benefits of AI technology.

02|28|25

Make a Difference in Rare Disease With Creativity, Data, and Innovation: Insights from Ann Cave

Learn the key takeaways and insights from a recent Med Ad News article about how to make a difference in rare disease marketing with creativity, data and innovation.

02|28|25

Rare but Prevalent: The Unequal Toll of Rare Diseases on Women

Learn how pharmaceutical companies can address gaps in women's health related to rare disease, and improve outcomes for patients.

02|20|25

Building Trust With Education and Innovation: Rare Disease Marketing

Rare and ultra-rare diseases face problems most brands do … turned up to 11. Budgets? Smaller. Patient pool? Even smaller. Healthcare providers (HCPs) who understand the condition? Sometimes even smaller than that. Treatment options can be limited, access can be hard to find and diagnosis time can sometimes be measured in decades rather than months. […]

02|06|25

Pharma Marketing and the Super Bowl: A Missed Opportunity?

During the Super Bowl, is when we see some of the most entertaining and memorable commercials. However, pharmaceutical companies often remain on the sidelines during this prime advertising opportunity. In a recent article in MM+M, pharma industry thought leaders, including John Kenny, Chief Strategy Officer, and Susan Perlbachs, Chief Creative Officer, offer their insights as to why pharma brands are hesitant to invest in Super Bowl ads despite the massive audience.

01|28|25

Pharma Marketing in 2025: Talking Trends With Angela Tenuta

In a rapidly evolving industry, staying ahead of the curve is critical. In PM360's article, “What Is Pharma Marketing in 2025?” Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. Read the blog to learn more.

01|24|25

Creating Award-Winning Work: Insights From Susan Perlbachs With Muse by Clios

In a recent interview with Muse by Clios, Susan Perlbachs, Chief Creative Officer, offered profound insights into the ever-changing world of healthcare advertising. Dive into our blog to discover the secrets behind creating award-winning campaigns and explore inspiring examples.

12|13|24

Global Health Equity: Moving From Wish List to To-Do List

This excerpt is from a recent interview with Angela Tenuta, President of EVERSANA INTOUCH, featured in PharmaLive where she emphasizes the importance of addressing disparities in healthcare access and outcomes across different populations. It highlights actionable steps and innovative approaches that can be taken to ensure equitable healthcare for all.